Publication Beamlines Strategic Pillar
Gaultois, M.W. (2011). Final-state effects in X-ray spectra from transition metal oxides and silicates. Canada, SK: University of Saskatchewan. . HXMA, SGM, VLS-PGM
Kharbanda, Neha (2011). Engineering the (S)-3-O-geranyl-geranyl-glyceryl phosphate synthase (GGGPS) monomer from its dimer. Supervisor: Pai, Emil F.. Ontario, Canada: University of Toronto. http://hdl.handle.net/1807/29571. CMCF-ID Materials
MacDonald, M.A. (2011). X-ray Spectroscopic Studies of Gold-thiolate Nanoclusters. Supervisor: Zhang, Peng. Nova Scotia, Canada: Dalhousie University. http://hdl.handle.net/10222/13980. CLS-APS, HXMA, SGM, SXRMB, VLS-PGM Materials
Mohanty, S. (2011). Effect of Citric Acid on Hydrotreating Activity of NiMo Catalysts. Canada, SK: University of Saskatchewan. . SXRMB
Mostaghimi Ghomi; Homa (2011). Adiabatic shear localization in AISI 1340 and 4340 steels: The influence of microstructure and geometry. Supervisor: Odeshi, Akindele Gabriel. Saskatoon, Saskatchewan, Canada: University of Saskatchewan. http://ecommons.usask.ca/handle/10388/ETD-2011-09-164. SM Materials
Roberts, Joseph N. (2011). Identification and characterization of DyP peroxidases from Rhodococcus jostii RHA1. Supervisor: Eltis, Lindsay. British Columbia, Canada: University of British Columbia. http://hdl.handle.net/2429/31830. CMCF-ID Materials
Rutherford, H. (2011). Structural Investigation of Liposomes: Effect of Phospholipid Hydrocarbon Length and the Incorporation of Sphingomyelin. Canada, SK: University of Saskatchewan. . MID-IR
Schaffer, Melissa Dawn (2011). High aspect ratio microstructure coupler. Supervisor: Klymyshyn, David. Saskatchewan, Canada: University of Saskatchewan. http://hdl.handle.net/10388/etd-02232011-211654. SYLMAND Materials
Walker; T. (2011). Authentic scientific inquiry, student engagement and transformational learning: are they related?. Canada, SK: CLS. https://harvest.usask.ca/bitstream/handle/10388/ETD-2011-09-224/ThesisVersionFinalFormatJan2012.pdf?sequence=5. BMIT-BM, FAR-IR, HXMA, MID-IR, SGM, SM, SXRMB, VESPERS, VLS-PGM
(2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A.
(2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A.
(2021). ANTIBODY. Patent Number: PT3311170T.
(2021). MODELING TEST. Patent Number: PT3311169T.
(2021). Stable heterodimeric antibody design with mutations in the fc domain. Patent Number: PT2773671T.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 요한 프란손; 로빈 매튜 할렛; 모니카 파스쿠알 가르시아 et al. (2021). Combination of LIF inhibitor and PD-1 axis inhibitor for use in treating cancer. Patent Number: KR20210021287A.